Actinium Pharmaceuticals (ATNM)
NYSE MKT:ATNM
Holding ATNM?
Track your performance easily

Actinium Pharmaceuticals (ATNM) Financial Statements

2,159 Followers

Actinium Pharmaceuticals Financial Overview

Actinium Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.516; its P/E ratio is -1.27; Actinium Pharmaceuticals is scheduled to report earnings on March 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--$ 81.00K--
Gross Profit--$ 81.00K--
EBIT$ -11.35M$ -9.60M$ -10.34M$ -14.35M$ -15.18M
EBITDA$ -11.16M$ -9.38M$ -10.14M$ -14.15M$ -14.97M
Net Income Common Stockholders$ -11.35M$ -8.67M$ -9.32M$ -13.28M$ -15.18M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 86.04M$ 84.06M$ 76.68M$ 82.98M$ 91.28M
Total Assets$ 89.86M$ 88.35M$ 81.44M$ 88.94M$ 99.05M
Total Debt$ 1.85M$ 9.49M$ 10.07M$ 10.36M$ 9.15M
Net Debt$ -84.19M$ -74.56M$ -66.61M$ -72.62M$ -82.13M
Total Liabilities$ 46.03M$ 44.49M$ 45.07M$ 45.36M$ 45.97M
Stockholders Equity$ 43.84M$ 43.86M$ 36.38M$ 43.58M$ 53.08M
Cash Flow-
Free Cash Flow$ -7.97M$ -7.38M$ -7.49M$ -11.15M$ -13.69M
Operating Cash Flow$ -7.97M$ -7.37M$ -7.49M$ -11.13M$ -13.64M
Investing Cash Flow-$ -11.00K-$ -30.00K$ -47.00K
Financing Cash Flow$ 9.95M$ 14.77M$ 1.19M$ 2.86M$ 10.05M
Currency in USD

Actinium Pharmaceuticals Earnings and Revenue History

Actinium Pharmaceuticals Debt to Assets

Actinium Pharmaceuticals Cash Flow

Actinium Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis